BioSpace News Archive

The Healthcare Financial Management Association (HFMA) today announced that, following its Peer Review process, Premier, Inc.’s PINC AI™ InflowHealth solution has been awarded the “Peer Reviewed by HFMA®” designation.

SHINE Technologies, LLC, a next-generation fusion technology company, announced the appointment of Dr. Frederick Robertson to the company’s board of directors.

The College of American Pathologists and American Society of Clinical Oncology have reaffirmed the Human Epidermal Growth Factor Receptor 2 Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.

In 2021, the Alkermes Inspiration Grants program funded nonprofit programs providing support for patient communities in the areas of addiction, serious mental illness and cancer.

Lyell Immunopharma, Inc. (Nasdaq: LYEL) today announced that members of its senior management team will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14 at 2:00pm PT.

Med-Life Discoveries, LP (“MLD”, or the “Company”), is a Canadian biopharmaceutical company dedicated to advancing a therapy to reduce symptoms for a devastating pediatric rare disease, Rhizomelic chondrodysplasia punctata (RCDP),

NanOlogy LLC, a clinical-stage oncology company, announces a presentation of clinical research involving its large surface area microparticle investigational drugs at DDW 2023 in May and publication at ASCO Annual Meeting in June.

DURECT Corporation announced that it has completed enrollment in its Phase 2b AHFIRM clinical trial investigating larsucosterol for the treatment of patients with severe alcohol-associated hepatitis, achieving its enrollment target of 300 patients.

Teleflex Incorporated today announced it will feature the Wattson ® Temporary Pacing Guidewire – the first commercially available bipolar temporary pacing guidewire designed specifically for use during TAVR and BAV – at TVT: The Structural Heart Summit, June 7-10 at the Phoenix Convention Center-West.

Prenosis Inc. , an artificial intelligence company enabling precision medicine in acute care, announced today it has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), a U.S. government agency.